Rocamboli Stephen
SEC-identified person · CIK 1221451 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Esperion Therapeutics, Inc. ESPR | Director | filed 2022 - 2025 |
| TFF Pharmaceuticals, Inc. TFFP | Director | filed 2019 - 2024 |
| Vioquest Pharmaceuticals, Inc. VQPH | Director · Secretary | filed 2007 - 2008 |
| Chitina Sciences, INC. | Director · President and Secretary | filed 2006 - 2008 |
| Cordova Sciences, INC. | Director · President and Secretary | filed 2006 - 2008 |
| Bristol BAY Sciences, INC. | Director · President and Secretary | filed 2006 - 2008 |
| Arctic Acquisition Corp. | Director · President and Secretary | filed 2006 - 2008 |
| Velcera, INC. VLCR | Director · Secretary | filed 2007 - 2007 |
| Innovive Pharmaceuticals, Inc. NA | Director · Secretary | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.